دورية أكاديمية
أعرض في EDS

Effect of a nutrition education programme on the metabolic syndrome in type 2 diabetes mellitus patients at a level 5 Hospital in Kenya: "a randomized controlled trial".

التفاصيل البيبلوغرافية
العنوان: Effect of a nutrition education programme on the metabolic syndrome in type 2 diabetes mellitus patients at a level 5 Hospital in Kenya: "a randomized controlled trial".
المؤلفون: Thuita AW; School of Food and Nutrition Sciences, Department of Human Nutrition Sciences, Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya., Kiage BN; School of Food and Nutrition Sciences, Department of Human Nutrition Sciences, Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya., Onyango AN; School of Food and Nutrition Sciences, Department of Human Nutrition Sciences, Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya., Makokha AO; School of Food and Nutrition Sciences, Department of Human Nutrition Sciences, Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya.
المصدر: BMC nutrition [BMC Nutr] 2020 Aug 04; Vol. 6, pp. 30. Date of Electronic Publication: 2020 Aug 04 (Print Publication: 2020).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101672434 Publication Model: eCollection Cited Medium: Internet ISSN: 2055-0928 (Electronic) Linking ISSN: 20550928 NLM ISO Abbreviation: BMC Nutr Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: London : BioMed Central, [2015]-
مستخلص: Background: Type 2 diabetes mellitus (T2D), is a life-threatening condition of global public health concern. It worsens in the presence of the metabolic syndrome (MetS), a complex disorder characterized by co-occurrence of at least three of such factors as hypertension, obesity, dyslipidemia and insulin resistance. However, lifestyle interventions reduce the risk of both MetS and T2D, and nutrition education can empower individuals on the appropriate, lifestyle changes. The aim of the current study was to evaluate the effect of a nutrition education programme, with and without inclusion of peer to peer support, on MetS in T2D patients.
Methods: This was a randomized controlled trial with two intervention groups and one control. One of the intervention groups involved a nutrition education programme with peer-to-peer support (NEP); the other involved only the education program, while the control received standard care. Each group had 51 participants. The nutrition education programme was conducted for 2 h per week for 8 weeks. In addition, the NEP had weekly peer-to-peer interactions for 8 weeks. All groups had follow-up sessions for 6 months. Data on MetS risk factors as well as food intake patterns and physical activity levels were taken at baseline and at different time points during the study. Analysis of Co-variance and regression were used in the analysis.
Results: The MetS prevalence improved in the NEP (90 to 52%) and NE (86 to 69%), while it worsened in C (88 to 91%). There was improvement in the mean values of the anthropometric parameters in the NEP and NE which worsened in the control group. There was a general improvement in mean values of blood lipids, fasting blood glucose and HbA1c in all the groups, with NEP showing the greatest improvements, followed by NE, except for triglycerides and HDL where the control group had better improvement than the NE. Changes in the anthropometric and metabolic indicators mirrored the changes in food intake patterns and physical activity, where the greatest improvements occurred in the NEP.
Conclusions: Nutrition education with inclusion of peer to peer support was of clinical benefit in improving metabolic outcomes and reducing MetS in T2DM patients.
Trial Registration: The study has been registered retrospectively by Pan African Clinical Trial Registry; Registration No: PACTR201910518676391.
Competing Interests: Competing interestsThe authors declare that they have no competing interests.
(© The Author(s) 2020.)
References: Hormones (Athens). 2012 Jul-Sep;11(3):316-24. (PMID: 22908064)
Diabetol Metab Syndr. 2010 Nov 11;2:67. (PMID: 21067623)
BMC Med. 2012 Nov 14;10:138. (PMID: 23151238)
Int J Chronic Dis. 2017;2017:8765804. (PMID: 28293668)
Diabetes Res Clin Pract. 2012 Apr;96(1):91-7. (PMID: 22553777)
Annu Rev Public Health. 2014;35:363-83. (PMID: 24387085)
J Diabetes Investig. 2015 Jul;6(4):479-86. (PMID: 26221528)
BMC Fam Pract. 2013 Jan 08;14:5. (PMID: 23297781)
J Clin Endocrinol Metab. 2008 Nov;93(11 Suppl 1):S9-30. (PMID: 18987276)
PeerJ. 2018 Apr 12;6:e4578. (PMID: 29666753)
J Lipid Res. 2010 Nov;51(11):3364-9. (PMID: 20688754)
Diabetes Care. 2012 Apr;35(4):887-93. (PMID: 22374643)
Rev Lat Am Enfermagem. 2016 Nov 28;24:e2848. (PMID: 27901223)
JAMA. 2002 Jan 16;287(3):356-9. (PMID: 11790215)
Med J Islam Repub Iran. 2016 Nov 19;30:442. (PMID: 28210607)
Public Health Nutr. 2016 Jan;19(1):142-55. (PMID: 25872641)
Acta Biochim Pol. 2013;60(3):401-3. (PMID: 24051439)
Circulation. 2009 Oct 20;120(16):1640-5. (PMID: 19805654)
Cardiol Res Pract. 2014;2014:943162. (PMID: 24711954)
World Health Organ Tech Rep Ser. 1995;854:1-452. (PMID: 8594834)
Obes Rev. 2015 Jan;16(1):1-12. (PMID: 25407540)
JRSM Cardiovasc Dis. 2016 Feb 25;5:2048004016633371. (PMID: 26998259)
J Multidiscip Healthc. 2017 Aug 11;10:293-300. (PMID: 28860796)
BMJ Open. 2015 Jul 15;5(7):e007635. (PMID: 26179646)
Clin Chem. 1982 Oct;28(10):2088-94. (PMID: 7127736)
Clin Chem. 1972 Jun;18(6):499-502. (PMID: 4337382)
Clin Chem. 1973 May;19(5):476-82. (PMID: 4703655)
Nepal Med Coll J. 2013 Mar;15(1):50-5. (PMID: 24592795)
Diabetol Metab Syndr. 2012 May 31;4(1):22. (PMID: 22650602)
Diabetes Care. 2011 Sep;34(9):1926-31. (PMID: 21775748)
Clin Chem. 1983 Dec;29(12):2026-30. (PMID: 6640896)
Clin Chem. 1989 Jul;35(7):1486-91. (PMID: 2758594)
Clin Chem. 1974 Apr;20(4):470-5. (PMID: 4818200)
Clin Exp Hypertens. 2017;39(1):8-16. (PMID: 28071980)
Arq Bras Cardiol. 2006 Dec;87(6):728-34. (PMID: 17262110)
PLoS One. 2015 Mar 18;10(3):e0120277. (PMID: 25785452)
Clin Chem. 1958 Dec;4(6):462-75. (PMID: 13608908)
Metab Syndr Relat Disord. 2009 Apr;7(2):119-24. (PMID: 18928398)
فهرسة مساهمة: Keywords: Metabolic syndrome; Type 2 diabetes mellitus and cardiovascular risk
تواريخ الأحداث: Date Created: 20200811 Latest Revision: 20231111
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC7401230
DOI: 10.1186/s40795-020-00355-6
PMID: 32774875
قاعدة البيانات: MEDLINE
الوصف
تدمد:2055-0928
DOI:10.1186/s40795-020-00355-6